Medically-supervised hormone therapy remains the most effective way to extend amounts of bioavailable growth hormone3. The impact of somatropin (Nutropin AQ) on visceral adipose tissue is evaluated in an open-label trial of Grownup sufferers with both equally childhood-onset and adult-onset GH deficiency. Doses of somatropin of around 0.012 mg/kg